Jonathan L. Coloff
NIH Rank #8021
- R01 Holder
- Translational
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8439442Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
- Physiology
NIH Funding · FY2024
Linked Award Amount
$1.6M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#8,021
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Jonathan L. Coloff as a PI. Multi-PI records show the full award amount for context.
- 5R01CA280737-02R01Therapeutic enzyme depletion of L-serine for cancer treatment$598.6Kaward amount
- 5R01CA200669-08R01Estrogen Receptor and NFkB Crosstalk in Breast Cancer$453.1Kaward amount
- 5R37CA251216-04R37Targeting Serine Auxotrophy in Luminal Breast Cancer$341.7Kaward amount
- 5R21CA276820-02R21SQLE and Sterols Contribute to Racial Disparity in ER+ Breast Cancer Patient Survival$177.5Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Jonathan L. Coloff as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Illinois at Chicago
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8021
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jonathan L. Coloff.